<VariationArchive VariationID="407079" VariationName="NM_000410.4(HFE):c.546_547del (p.Leu183fs)" VariationType="Deletion" Accession="VCV000407079" Version="45" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2017-04-17" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="395689" VariationID="407079">
      <GeneList>
        <Gene Symbol="HFE" FullName="homeostatic iron regulator" GeneID="3077" HGNC_ID="HGNC:4886" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="26087429" stop="26098343" display_start="26087429" display_stop="26098343" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="26087508" stop="26095468" display_start="26087508" display_stop="26095468" Strand="+" />
          </Location>
          <OMIM>613609</OMIM>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000410.4(HFE):c.546_547del (p.Leu183fs)</Name>
      <CanonicalSPDI>NC_000006.12:26091518:CC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="26091519" stop="26091520" display_start="26091519" display_stop="26091520" variantLength="2" positionVCF="26091518" referenceAlleleVCF="ACC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="26091747" stop="26091748" display_start="26091747" display_stop="26091748" variantLength="2" positionVCF="26091746" referenceAlleleVCF="ACC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L183fs</ProteinChange>
      <ProteinChange>L95fs</ProteinChange>
      <ProteinChange>L160fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.26091747_26091748del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.26091747_26091748del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.26091519_26091520del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.26091519_26091520del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008720.2" sequenceAccession="NG_008720" sequenceVersion="2" change="g.9239_9240del">
            <Expression>NG_008720.2:g.9239_9240del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000410.4" sequenceAccession="NM_000410" sequenceVersion="4" change="c.546_547del" MANESelect="true">
            <Expression>NM_000410.4:c.546_547del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000401.1" sequenceAccession="NP_000401" sequenceVersion="1" change="p.Leu183fs">
            <Expression>NP_000401.1:p.Leu183fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001300749.3" sequenceAccession="NM_001300749" sequenceVersion="3" change="c.546_547delCC">
            <Expression>NM_001300749.3:c.546_547delCC</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001287678.1" sequenceAccession="NP_001287678" sequenceVersion="1" change="p.Leu183Glyfs">
            <Expression>NP_001287678.1:p.Leu183Glyfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001384164.1" sequenceAccession="NM_001384164" sequenceVersion="1" change="c.546_547del">
            <Expression>NM_001384164.1:c.546_547del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001371093.1" sequenceAccession="NP_001371093" sequenceVersion="1" change="p.Leu183fs">
            <Expression>NP_001371093.1:p.Leu183fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406751.1" sequenceAccession="NM_001406751" sequenceVersion="1" change="c.546_547delCC">
            <Expression>NM_001406751.1:c.546_547delCC</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393680.1" sequenceAccession="NP_001393680" sequenceVersion="1" change="p.Leu183Glyfs">
            <Expression>NP_001393680.1:p.Leu183Glyfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406752.1" sequenceAccession="NM_001406752" sequenceVersion="1" change="c.282_283delCC">
            <Expression>NM_001406752.1:c.282_283delCC</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393681.1" sequenceAccession="NP_001393681" sequenceVersion="1" change="p.Leu95Glyfs">
            <Expression>NP_001393681.1:p.Leu95Glyfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139006.3" sequenceAccession="NM_139006" sequenceVersion="3" change="c.546_547del">
            <Expression>NM_139006.3:c.546_547del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_620575.1" sequenceAccession="NP_620575" sequenceVersion="1" change="p.Leu183fs">
            <Expression>NP_620575.1:p.Leu183fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139007.3" sequenceAccession="NM_139007" sequenceVersion="3" change="c.282_283del">
            <Expression>NM_139007.3:c.282_283del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_620576.1" sequenceAccession="NP_620576" sequenceVersion="1" change="p.Leu95fs">
            <Expression>NP_620576.1:p.Leu95fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139008.3" sequenceAccession="NM_139008" sequenceVersion="3" change="c.282_283del">
            <Expression>NM_139008.3:c.282_283del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_620577.1" sequenceAccession="NP_620577" sequenceVersion="1" change="p.Leu95fs">
            <Expression>NP_620577.1:p.Leu95fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139009.3" sequenceAccession="NM_139009" sequenceVersion="3" change="c.477_478del">
            <Expression>NM_139009.3:c.477_478del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_620578.1" sequenceAccession="NP_620578" sequenceVersion="1" change="p.Leu160fs">
            <Expression>NP_620578.1:p.Leu160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139004.3" sequenceAccession="NM_139004" sequenceVersion="3" change="c.340+415_340+416del">
            <Expression>NM_139004.3:c.340+415_340+416del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139003.3" sequenceAccession="NM_139003" sequenceVersion="3" change="c.340+415_340+416del">
            <Expression>NM_139003.3:c.340+415_340+416del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139010.3" sequenceAccession="NM_139010" sequenceVersion="3" change="c.77-1166_77-1165del">
            <Expression>NM_139010.3:c.77-1166_77-1165del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139011.3" sequenceAccession="NM_139011" sequenceVersion="3" change="c.77-1600_77-1599del">
            <Expression>NM_139011.3:c.77-1600_77-1599del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_748" sequenceAccession="LRG_748">
            <Expression>LRG_748:g.9239_9240del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_748t1" sequenceAccession="LRG_748t1">
            <Expression>LRG_748t1:c.546_547del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_748p1" sequenceAccession="LRG_748p1" change="p.Leu183Glyfs">
            <Expression>LRG_748p1:p.Leu183Glyfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA3666670" DB="ClinGen" />
        <XRef Type="rs" ID="765804978" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000410.4(HFE):c.546_547del (p.Leu183fs) AND Hereditary hemochromatosis" Accession="RCV002230337" Version="13">
        <ClassifiedConditionList TraitSetID="21210">
          <ClassifiedCondition DB="MedGen" ID="C0392514">Hereditary hemochromatosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000410.4(HFE):c.546_547del (p.Leu183fs) AND multiple conditions" Accession="RCV002489030" Version="8">
        <ClassifiedConditionList TraitSetID="82006">
          <ClassifiedCondition DB="MedGen" ID="C1863052">Alzheimer disease type 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268323">Familial porphyria cutanea tarda</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3469186">Hemochromatosis type 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2673520">Microvascular complications of diabetes, susceptibility to, 7</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3280096">Transferrin serum level quantitative trait locus 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0162532">Variegate porphyria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-12" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000410.4(HFE):c.546_547del (p.Leu183fs) AND Hemochromatosis type 1" Accession="RCV003126743" Version="8">
        <ClassifiedConditionList TraitSetID="7">
          <ClassifiedCondition DB="MedGen" ID="C3469186">Hemochromatosis type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-28" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-04-17" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27518069</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="21210" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33108" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary hemochromatosis</ElementValue>
                <XRef ID="Hereditary+hemochromatosis/8521" DB="Genetic Alliance" />
                <XRef ID="MONDO:0006507" DB="MONDO" />
                <XRef ID="35400008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HFE</ElementValue>
                <XRef Type="MIM" ID="235200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HH</ElementValue>
                <XRef Type="MIM" ID="235200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10746" />
                <XRef ID="10746" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000603934" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">HFE hemochromatosis is characterized by inappropriately high absorption of iron by the small intestinal mucosa. The phenotypic spectrum of HFE hemochromatosis includes: Persons with clinical HFE hemochromatosis, in whom manifestations of end-organ damage secondary to iron overload are present; Individuals with biochemical HFE hemochromatosis, in whom transferrin-iron saturation is increased and the only evidence of iron overload is increased serum ferritin concentration; and Non-expressing p.Cys282Tyr homozygotes, in whom neither clinical manifestations of HFE hemochromatosis nor iron overload are present. Clinical HFE hemochromatosis is characterized by excessive storage of iron in the liver, skin, pancreas, heart, joints, and anterior pituitary gland. In untreated individuals, early symptoms include: abdominal pain, weakness, lethargy, weight loss, arthralgias, diabetes mellitus; and increased risk of cirrhosis when the serum ferritin is higher than 1,000 ng/mL. Other findings may include progressive increase in skin pigmentation, congestive heart failure, and/or arrhythmias, arthritis, and hypogonadism. Clinical HFE hemochromatosis is more common in men than women.</Attribute>
                <XRef ID="NBK1440" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301613</ID>
                <ID Source="BookShelf">NBK1440</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987432</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2006">
                <ID Source="PubMed">16880462</ID>
              </Citation>
              <Citation Type="general" Abbrev="AASLD, 2011">
                <ID Source="pmc">3149125</ID>
              </Citation>
              <XRef ID="C0392514" DB="MedGen" />
              <XRef ID="MONDO:0006507" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS235200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9582" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HFE-Associated Hereditary Hemochromatosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hemochromatosis type 1</ElementValue>
                <XRef ID="MONDO:0021001" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HFE1</ElementValue>
                <XRef Type="MIM" ID="235200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HFE-HH</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000501371" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558542" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560567" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560323" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000264968" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508786" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260619" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507663" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000531271" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521586" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000271417" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509340" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332464" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500638" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028914" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501267" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500300" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528695" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558915" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508970" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10417" />
                <XRef ID="10417" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">HFE hemochromatosis is characterized by inappropriately high absorption of iron by the small intestinal mucosa. The phenotypic spectrum of HFE hemochromatosis includes: Persons with clinical HFE hemochromatosis, in whom manifestations of end-organ damage secondary to iron overload are present; Individuals with biochemical HFE hemochromatosis, in whom transferrin-iron saturation is increased and the only evidence of iron overload is increased serum ferritin concentration; and Non-expressing p.Cys282Tyr homozygotes, in whom neither clinical manifestations of HFE hemochromatosis nor iron overload are present. Clinical HFE hemochromatosis is characterized by excessive storage of iron in the liver, skin, pancreas, heart, joints, and anterior pituitary gland. In untreated individuals, early symptoms include: abdominal pain, weakness, lethargy, weight loss, arthralgias, diabetes mellitus; and increased risk of cirrhosis when the serum ferritin is higher than 1,000 ng/mL. Other findings may include progressive increase in skin pigmentation, congestive heart failure, and/or arrhythmias, arthritis, and hypogonadism. Clinical HFE hemochromatosis is more common in men than women.</Attribute>
                <XRef ID="NBK1440" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301613</ID>
                <ID Source="BookShelf">NBK1440</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987432</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2006">
                <ID Source="PubMed">16880462</ID>
              </Citation>
              <Citation Type="general" Abbrev="AASLD, 2011">
                <ID Source="pmc">3149125</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="139498" DB="Orphanet" />
              <XRef ID="465508" DB="Orphanet" />
              <XRef ID="C3469186" DB="MedGen" />
              <XRef ID="MONDO:0021001" DB="MONDO" />
              <XRef Type="MIM" ID="235200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="82006" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="3370" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Porphyria, South African type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Protoporphyrinogen oxidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PPOX deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Variegate porphyria</ElementValue>
                <XRef ID="Variegate+porphyria/7355" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008297" DB="MONDO" />
                <XRef ID="58275005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VP</ElementValue>
                <XRef Type="MIM" ID="176200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7848" />
                <XRef ID="7848" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Variegate porphyria (VP) is both a cutaneous porphyria (with chronic blistering skin lesions) and an acute porphyria (with severe episodic neurovisceral symptoms). The most common manifestation of VP is adult-onset cutaneous blistering lesions (subepidermal vesicles, bullae, and erosions that crust over and heal slowly) of sun-exposed skin, especially the hands and face. Other chronic skin findings include milia, scarring, thickening, and areas of decreased and increased skin pigmentation. Facial hyperpigmentation and hypertrichosis may occur. Cutaneous manifestations may improve in winter and be less prevalent in northern regions and in dark-skinned individuals. Acute neurovisceral symptoms can occur any time after puberty, but less often in the elderly. Acute manifestations are highly variable, but may be similar from episode to episode in a person with recurrent attacks; not all manifestations are present in a single episode; and acute symptoms may become chronic. Symptoms are more common in women than men. The most common manifestations are abdominal pain; constipation; pain in the back, chest, and extremities; anxiety; seizures; and a primarily motor neuropathy resulting in muscle weakness that may progress to quadriparesis and respiratory paralysis. Psychiatric disturbances and autonomic neuropathy can also be observed. Acute attacks may be severe and are potentially fatal.</Attribute>
                <XRef ID="NBK121283" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AcuteHepaticPorphyria.pdf</URL>
                <CitationText>Orphanet, Acute hepatic porphyria neuro-visceral crisis, 2007</CitationText>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23409300</ID>
                <ID Source="BookShelf">NBK121283</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_CutaneousPorphyrias.pdf</URL>
                <CitationText>Orphanet emergency guideline: Cutaneous porphyrias, 2007</CitationText>
              </Citation>
              <XRef ID="79473" DB="Orphanet" />
              <XRef ID="C0162532" DB="MedGen" />
              <XRef ID="MONDO:0008297" DB="MONDO" />
              <XRef Type="MIM" ID="176200" DB="OMIM" />
            </Trait>
            <Trait ID="6591" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ALZHEIMER DISEASE, FAMILIAL, 1</ElementValue>
                <XRef Type="MIM" ID="104300" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="104760.0021" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Alzheimer disease type 1</ElementValue>
                <XRef ID="MONDO:0007088" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="Allelic variant" ID="104760.0022" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AD1</ElementValue>
                <XRef Type="MIM" ID="104300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9465" />
                <XRef ID="9465" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301340</ID>
                <ID Source="BookShelf">NBK1161</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20831773</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHRQ, 2010">
                <ID Source="PubMed">21500874</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <Citation Type="general" Abbrev="CCCDTD, 2014">
                <ID Source="PubMed">24829003</ID>
              </Citation>
              <Citation Type="general" Abbrev="CCCDTD, 2020">
                <ID Source="PubMed">32725777</ID>
                <ID Source="pmc">7984031</ID>
              </Citation>
              <XRef ID="C1863052" DB="MedGen" />
              <XRef ID="MONDO:0007088" DB="MONDO" />
              <XRef Type="MIM" ID="104300" DB="OMIM" />
            </Trait>
            <Trait ID="9601" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PCT, TYPE II</ElementValue>
                <XRef Type="MIM" ID="176100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PORPHYRIA CUTANEA TARDA, TYPE II</ElementValue>
                <XRef Type="MIM" ID="176100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PORPHYRIA, HEPATOCUTANEOUS TYPE</ElementValue>
                <XRef Type="MIM" ID="176100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">UROD DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="176100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">UROPORPHYRINOGEN DECARBOXYLASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="176100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial porphyria cutanea tarda</ElementValue>
                <XRef ID="Familial+porphyria+cutanea+tarda/8404" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008296" DB="MONDO" />
                <XRef ID="59229005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PCT, ''FAMILIAL'' TYPE</ElementValue>
                <XRef Type="MIM" ID="176100" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PCT</ElementValue>
                <XRef Type="MIM" ID="176100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17750" />
                <XRef ID="17750" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Familial porphyria cutanea tarda (F-PCT) is characterized by: skin findings including blistering over the dorsal aspects of the hands and other sun-exposed areas of skin, skin friability after minor trauma, facial hypertrichosis and hyperpigmentation, and severe thickening of affected skin areas (pseudoscleroderma); and an increased risk for hepatocellular carcinoma (HCC).</Attribute>
                <XRef ID="NBK143129" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">UROD-Related Porphyrias</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23741761</ID>
                <ID Source="BookShelf">NBK143129</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24175354</ID>
                <ID Source="BookShelf">NBK169003</ID>
              </Citation>
              <XRef ID="101330" DB="Orphanet" />
              <XRef ID="443062" DB="Orphanet" />
              <XRef ID="C0268323" DB="MedGen" />
              <XRef ID="MONDO:0008296" DB="MONDO" />
              <XRef Type="MIM" ID="176100" DB="OMIM" />
            </Trait>
            <Trait ID="9582" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HFE-Associated Hereditary Hemochromatosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hemochromatosis type 1</ElementValue>
                <XRef ID="MONDO:0021001" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HFE1</ElementValue>
                <XRef Type="MIM" ID="235200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HFE-HH</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000501371" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551894" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558542" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560567" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560323" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000264968" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508786" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260619" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507663" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000531271" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521586" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000271417" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509340" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332464" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500638" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000028914" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501267" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500300" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528695" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558915" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508970" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10417" />
                <XRef ID="10417" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">HFE hemochromatosis is characterized by inappropriately high absorption of iron by the small intestinal mucosa. The phenotypic spectrum of HFE hemochromatosis includes: Persons with clinical HFE hemochromatosis, in whom manifestations of end-organ damage secondary to iron overload are present; Individuals with biochemical HFE hemochromatosis, in whom transferrin-iron saturation is increased and the only evidence of iron overload is increased serum ferritin concentration; and Non-expressing p.Cys282Tyr homozygotes, in whom neither clinical manifestations of HFE hemochromatosis nor iron overload are present. Clinical HFE hemochromatosis is characterized by excessive storage of iron in the liver, skin, pancreas, heart, joints, and anterior pituitary gland. In untreated individuals, early symptoms include: abdominal pain, weakness, lethargy, weight loss, arthralgias, diabetes mellitus; and increased risk of cirrhosis when the serum ferritin is higher than 1,000 ng/mL. Other findings may include progressive increase in skin pigmentation, congestive heart failure, and/or arrhythmias, arthritis, and hypogonadism. Clinical HFE hemochromatosis is more common in men than women.</Attribute>
                <XRef ID="NBK1440" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301613</ID>
                <ID Source="BookShelf">NBK1440</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987432</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2006">
                <ID Source="PubMed">16880462</ID>
              </Citation>
              <Citation Type="general" Abbrev="AASLD, 2011">
                <ID Source="pmc">3149125</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="139498" DB="Orphanet" />
              <XRef ID="465508" DB="Orphanet" />
              <XRef ID="C3469186" DB="MedGen" />
              <XRef ID="MONDO:0021001" DB="MONDO" />
              <XRef Type="MIM" ID="235200" DB="OMIM" />
            </Trait>
            <Trait ID="9587" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Transferrin serum level quantitative trait locus 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TFQTL2</ElementValue>
                <XRef Type="MIM" ID="614193" DB="OMIM" />
              </Symbol>
              <XRef ID="C3280096" DB="MedGen" />
              <XRef Type="MIM" ID="614193" DB="OMIM" />
            </Trait>
            <Trait ID="5535" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Microvascular complications of diabetes 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Microvascular complications of diabetes, susceptibility to, 7</ElementValue>
                <XRef ID="MONDO:0012971" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MVCD7</ElementValue>
                <XRef Type="MIM" ID="612635" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">NEPHROPATHY, DIABETIC, SUSCEPTIBILITY TO</Attribute>
                <XRef Type="MIM" ID="612635" DB="OMIM" />
                <XRef ID="603933" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">NONPROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO</Attribute>
                <XRef Type="MIM" ID="612635" DB="OMIM" />
                <XRef ID="603933" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">PROLIFERATIVE RETINOPATHY, DIABETIC, SUSCEPTIBILITY TO</Attribute>
                <XRef Type="MIM" ID="612635" DB="OMIM" />
                <XRef ID="603933" DB="OMIM" />
              </AttributeSet>
              <XRef ID="C2673520" DB="MedGen" />
              <XRef ID="MONDO:0012971" DB="MONDO" />
              <XRef Type="MIM" ID="612635" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5446042" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000410.4:c.546_547del|OMIM:104300;176100;176200;235200;612635;614193" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002785265" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000410.4:c.546_547del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="104300" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="176100" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="176200" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="235200" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612635" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614193" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7103033" SubmissionDate="2023-02-09" DateLastUpdated="2023-02-18" DateCreated="2023-02-18">
        <ClinVarSubmissionID localKey="NM_000410.4:c.546_547del|OMIM:235200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003801604" DateUpdated="2023-02-18" DateCreated="2023-02-18" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HFE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000410.4:c.546_547del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="235200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12834886</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1058979" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2017-04-17">
        <ClinVarSubmissionID localKey="960352|MedGen:C0392514" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000546060" DateUpdated="2024-02-20" DateCreated="2017-04-17" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27518069</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 407079). This variant has not been reported in the literature in individuals affected with HFE-related conditions. This variant is present in population databases (rs765804978, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Leu183Glyfs*60) in the HFE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HFE are known to be pathogenic (PMID: 27518069).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HFE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.26091747_26091748del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0392514" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2017March_Invitae</SubmissionName>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1058979" TraitType="Disease" MappingType="XRef" MappingValue="C0392514" MappingRef="MedGen">
        <MedGen CUI="C0392514" Name="Hereditary hemochromatosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446042" TraitType="Disease" MappingType="XRef" MappingValue="176100" MappingRef="OMIM">
        <MedGen CUI="C0268323" Name="Familial porphyria cutanea tarda" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7103033" TraitType="Disease" MappingType="XRef" MappingValue="235200" MappingRef="OMIM">
        <MedGen CUI="C3469186" Name="Hemochromatosis type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446042" TraitType="Disease" MappingType="XRef" MappingValue="176200" MappingRef="OMIM">
        <MedGen CUI="C0162532" Name="Variegate porphyria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446042" TraitType="Disease" MappingType="XRef" MappingValue="614193" MappingRef="OMIM">
        <MedGen CUI="C3280096" Name="Transferrin serum level quantitative trait locus 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446042" TraitType="Disease" MappingType="XRef" MappingValue="235200" MappingRef="OMIM">
        <MedGen CUI="C3469186" Name="Hemochromatosis type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446042" TraitType="Disease" MappingType="XRef" MappingValue="612635" MappingRef="OMIM">
        <MedGen CUI="C2673520" Name="Microvascular complications of diabetes, susceptibility to, 7" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446042" TraitType="Disease" MappingType="XRef" MappingValue="104300" MappingRef="OMIM">
        <MedGen CUI="C1863052" Name="Alzheimer disease type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

